Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial
Identifieur interne : 005561 ( Main/Curation ); précédent : 005560; suivant : 005562Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial
Auteurs : S. Van Dieren [Australie, Pays-Bas] ; S. Czernichow [France] ; J. Chalmers [Australie] ; A. P. Kengne [Australie, Pays-Bas, Afrique du Sud] ; B. E. De Galan [Pays-Bas] ; N. Poulter [Royaume-Uni] ; M. Woodward [Australie] ; J. W. J. Beulens [Pays-Bas] ; D. E. Grobbee [Pays-Bas] ; Y. T. Van Der Schouw [Pays-Bas] ; S. Zoungas [Australie]Source :
- Diabetes, Obesity and Metabolism [ 1462-8902 ] ; 2012-05.
Descripteurs français
- Wicri :
- topic : Collecte de données, Diabète, Glucose.
English descriptors
- KwdEn :
- Advance trial, Alpha glucosidase, Baseline, Baseline characteristics, Baseline predictors, Baseline weight, Blood therapy, Body weight, Cape town, Caucasian, Caucasian ethnicity, Data analysis, Data collection, Diabetes, Diabetes care, Diabetes mellitus, Different patterns, Different regimens, Dual therapy, Effect sizes, Ethnicity, Exclusive indicators, Gain weight, George institute, Gliclazide release, Global health, Glucose, Glucose control, Glycaemic control, Glycemic control, Greatest weight gain, Haemoglobin, Hba1c, Hba1c level, Hypoglycaemic events, Insulin, Insulin combinations, Intensive blood glucose control, Intensive treatment, Intensive treatment arms, Less weight gain, Macrovascular, Macrovascular disease, Medical research council, Metabolism table, Metformin, Metformin thiazol, Microvascular disease, Minimal weight gain, More participants, More patients, Multivariable models, National health, Oral agents, Oral medications, Original article, Original article diabetes, Patient characteristics, Potential predictors, Predictor, Randomized treatment, Sensitivity analysis, Several studies, Standard treatment, Substantial weight gain, Sulphonylurea, Sulphonylurea metformin, Sulphonylurea thiazol, Thiazolidinedione, Treatment allocation, Treatment combinations, Vascular disease, Vascular outcomes, Weight change, Weight changes, Weight gain, Weight gain group, Weight loss.
- Teeft :
- Advance trial, Alpha glucosidase, Baseline, Baseline characteristics, Baseline predictors, Baseline weight, Blood therapy, Body weight, Cape town, Caucasian, Caucasian ethnicity, Data analysis, Data collection, Diabetes, Diabetes care, Diabetes mellitus, Different patterns, Different regimens, Dual therapy, Effect sizes, Ethnicity, Exclusive indicators, Gain weight, George institute, Gliclazide release, Global health, Glucose, Glucose control, Glycaemic control, Glycemic control, Greatest weight gain, Haemoglobin, Hba1c, Hba1c level, Hypoglycaemic events, Insulin, Insulin combinations, Intensive blood glucose control, Intensive treatment, Intensive treatment arms, Less weight gain, Macrovascular, Macrovascular disease, Medical research council, Metabolism table, Metformin, Metformin thiazol, Microvascular disease, Minimal weight gain, More participants, More patients, Multivariable models, National health, Oral agents, Oral medications, Original article, Original article diabetes, Patient characteristics, Potential predictors, Predictor, Randomized treatment, Sensitivity analysis, Several studies, Standard treatment, Substantial weight gain, Sulphonylurea, Sulphonylurea metformin, Sulphonylurea thiazol, Thiazolidinedione, Treatment allocation, Treatment combinations, Vascular disease, Vascular outcomes, Weight change, Weight changes, Weight gain, Weight gain group, Weight loss.
Abstract
Aims: To determine the baseline characteristics and glucose‐lowering therapies associated with weight change among patients with type 2 diabetes.
Url:
DOI: 10.1111/j.1463-1326.2012.01556.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000924
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :000924
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000486
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005828
Links to Exploration step
ISTEX:305AA8190450073B3A0E52A1597718EF0CFD6E6BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial</title>
<author><name sortKey="Van Dieren, S" sort="Van Dieren, S" uniqKey="Van Dieren S" first="S." last="Van Dieren">S. Van Dieren</name>
</author>
<author><name sortKey="Czernichow, S" sort="Czernichow, S" uniqKey="Czernichow S" first="S." last="Czernichow">S. Czernichow</name>
</author>
<author><name sortKey="Chalmers, J" sort="Chalmers, J" uniqKey="Chalmers J" first="J." last="Chalmers">J. Chalmers</name>
</author>
<author><name sortKey="Kengne, A P" sort="Kengne, A P" uniqKey="Kengne A" first="A. P." last="Kengne">A. P. Kengne</name>
</author>
<author><name sortKey="De Galan, B E" sort="De Galan, B E" uniqKey="De Galan B" first="B. E." last="De Galan">B. E. De Galan</name>
</author>
<author><name sortKey="Poulter, N" sort="Poulter, N" uniqKey="Poulter N" first="N." last="Poulter">N. Poulter</name>
</author>
<author><name sortKey="Woodward, M" sort="Woodward, M" uniqKey="Woodward M" first="M." last="Woodward">M. Woodward</name>
</author>
<author><name sortKey="Beulens, J W J" sort="Beulens, J W J" uniqKey="Beulens J" first="J. W. J." last="Beulens">J. W. J. Beulens</name>
</author>
<author><name sortKey="Grobbee, D E" sort="Grobbee, D E" uniqKey="Grobbee D" first="D. E." last="Grobbee">D. E. Grobbee</name>
</author>
<author><name sortKey="Van Der Schouw, Y T" sort="Van Der Schouw, Y T" uniqKey="Van Der Schouw Y" first="Y. T." last="Van Der Schouw">Y. T. Van Der Schouw</name>
</author>
<author><name sortKey="Zoungas, S" sort="Zoungas, S" uniqKey="Zoungas S" first="S." last="Zoungas">S. Zoungas</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:305AA8190450073B3A0E52A1597718EF0CFD6E6B</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1111/j.1463-1326.2012.01556.x</idno>
<idno type="url">https://api.istex.fr/document/305AA8190450073B3A0E52A1597718EF0CFD6E6B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000924</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000924</idno>
<idno type="wicri:Area/Istex/Curation">000924</idno>
<idno type="wicri:Area/Istex/Checkpoint">000486</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000486</idno>
<idno type="wicri:doubleKey">1462-8902:2012:Van Dieren S:weight:changes:and</idno>
<idno type="wicri:Area/Main/Merge">005828</idno>
<idno type="wicri:Area/Main/Curation">005561</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial</title>
<author><name sortKey="Van Dieren, S" sort="Van Dieren, S" uniqKey="Van Dieren S" first="S." last="Van Dieren">S. Van Dieren</name>
<affiliation wicri:level="4"><country xml:lang="fr">Australie</country>
<wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
<settlement type="city">Sydney</settlement>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Czernichow, S" sort="Czernichow, S" uniqKey="Czernichow S" first="S." last="Czernichow">S. Czernichow</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Department of Nutrition, Ambroise Paré Hospital, University Versailles St‐Quentin, Boulogne‐Billancourt</wicri:regionArea>
<wicri:noRegion>Boulogne‐Billancourt</wicri:noRegion>
<wicri:noRegion>Boulogne‐Billancourt</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chalmers, J" sort="Chalmers, J" uniqKey="Chalmers J" first="J." last="Chalmers">J. Chalmers</name>
<affiliation wicri:level="4"><country xml:lang="fr">Australie</country>
<wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
<settlement type="city">Sydney</settlement>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
</author>
<author><name sortKey="Kengne, A P" sort="Kengne, A P" uniqKey="Kengne A" first="A. P." last="Kengne">A. P. Kengne</name>
<affiliation wicri:level="4"><country xml:lang="fr">Australie</country>
<wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
<settlement type="city">Sydney</settlement>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>South African Medical Research Council & University of Cape Town, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Galan, B E" sort="De Galan, B E" uniqKey="De Galan B" first="B. E." last="De Galan">B. E. De Galan</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen</wicri:regionArea>
<placeName><settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Poulter, N" sort="Poulter, N" uniqKey="Poulter N" first="N." last="Poulter">N. Poulter</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>National Heart and Lung Institute, Imperial College London, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Woodward, M" sort="Woodward, M" uniqKey="Woodward M" first="M." last="Woodward">M. Woodward</name>
<affiliation wicri:level="4"><country xml:lang="fr">Australie</country>
<wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
<settlement type="city">Sydney</settlement>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
</author>
<author><name sortKey="Beulens, J W J" sort="Beulens, J W J" uniqKey="Beulens J" first="J. W. J." last="Beulens">J. W. J. Beulens</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Grobbee, D E" sort="Grobbee, D E" uniqKey="Grobbee D" first="D. E." last="Grobbee">D. E. Grobbee</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Der Schouw, Y T" sort="Van Der Schouw, Y T" uniqKey="Van Der Schouw Y" first="Y. T." last="Van Der Schouw">Y. T. Van Der Schouw</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zoungas, S" sort="Zoungas, S" uniqKey="Zoungas S" first="S." last="Zoungas">S. Zoungas</name>
<affiliation wicri:level="4"><country xml:lang="fr">Australie</country>
<wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
<settlement type="city">Sydney</settlement>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Public Health, Monash University, Melbourne</wicri:regionArea>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Australie</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Diabetes, Obesity and Metabolism</title>
<title level="j" type="alt">DIABETES OBESITY METABOLISM</title>
<idno type="ISSN">1462-8902</idno>
<idno type="eISSN">1463-1326</idno>
<imprint><biblScope unit="vol">14</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="464">464</biblScope>
<biblScope unit="page" to="469">469</biblScope>
<biblScope unit="page-count">6</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2012-05">2012-05</date>
</imprint>
<idno type="ISSN">1462-8902</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1462-8902</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Advance trial</term>
<term>Alpha glucosidase</term>
<term>Baseline</term>
<term>Baseline characteristics</term>
<term>Baseline predictors</term>
<term>Baseline weight</term>
<term>Blood therapy</term>
<term>Body weight</term>
<term>Cape town</term>
<term>Caucasian</term>
<term>Caucasian ethnicity</term>
<term>Data analysis</term>
<term>Data collection</term>
<term>Diabetes</term>
<term>Diabetes care</term>
<term>Diabetes mellitus</term>
<term>Different patterns</term>
<term>Different regimens</term>
<term>Dual therapy</term>
<term>Effect sizes</term>
<term>Ethnicity</term>
<term>Exclusive indicators</term>
<term>Gain weight</term>
<term>George institute</term>
<term>Gliclazide release</term>
<term>Global health</term>
<term>Glucose</term>
<term>Glucose control</term>
<term>Glycaemic control</term>
<term>Glycemic control</term>
<term>Greatest weight gain</term>
<term>Haemoglobin</term>
<term>Hba1c</term>
<term>Hba1c level</term>
<term>Hypoglycaemic events</term>
<term>Insulin</term>
<term>Insulin combinations</term>
<term>Intensive blood glucose control</term>
<term>Intensive treatment</term>
<term>Intensive treatment arms</term>
<term>Less weight gain</term>
<term>Macrovascular</term>
<term>Macrovascular disease</term>
<term>Medical research council</term>
<term>Metabolism table</term>
<term>Metformin</term>
<term>Metformin thiazol</term>
<term>Microvascular disease</term>
<term>Minimal weight gain</term>
<term>More participants</term>
<term>More patients</term>
<term>Multivariable models</term>
<term>National health</term>
<term>Oral agents</term>
<term>Oral medications</term>
<term>Original article</term>
<term>Original article diabetes</term>
<term>Patient characteristics</term>
<term>Potential predictors</term>
<term>Predictor</term>
<term>Randomized treatment</term>
<term>Sensitivity analysis</term>
<term>Several studies</term>
<term>Standard treatment</term>
<term>Substantial weight gain</term>
<term>Sulphonylurea</term>
<term>Sulphonylurea metformin</term>
<term>Sulphonylurea thiazol</term>
<term>Thiazolidinedione</term>
<term>Treatment allocation</term>
<term>Treatment combinations</term>
<term>Vascular disease</term>
<term>Vascular outcomes</term>
<term>Weight change</term>
<term>Weight changes</term>
<term>Weight gain</term>
<term>Weight gain group</term>
<term>Weight loss</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Advance trial</term>
<term>Alpha glucosidase</term>
<term>Baseline</term>
<term>Baseline characteristics</term>
<term>Baseline predictors</term>
<term>Baseline weight</term>
<term>Blood therapy</term>
<term>Body weight</term>
<term>Cape town</term>
<term>Caucasian</term>
<term>Caucasian ethnicity</term>
<term>Data analysis</term>
<term>Data collection</term>
<term>Diabetes</term>
<term>Diabetes care</term>
<term>Diabetes mellitus</term>
<term>Different patterns</term>
<term>Different regimens</term>
<term>Dual therapy</term>
<term>Effect sizes</term>
<term>Ethnicity</term>
<term>Exclusive indicators</term>
<term>Gain weight</term>
<term>George institute</term>
<term>Gliclazide release</term>
<term>Global health</term>
<term>Glucose</term>
<term>Glucose control</term>
<term>Glycaemic control</term>
<term>Glycemic control</term>
<term>Greatest weight gain</term>
<term>Haemoglobin</term>
<term>Hba1c</term>
<term>Hba1c level</term>
<term>Hypoglycaemic events</term>
<term>Insulin</term>
<term>Insulin combinations</term>
<term>Intensive blood glucose control</term>
<term>Intensive treatment</term>
<term>Intensive treatment arms</term>
<term>Less weight gain</term>
<term>Macrovascular</term>
<term>Macrovascular disease</term>
<term>Medical research council</term>
<term>Metabolism table</term>
<term>Metformin</term>
<term>Metformin thiazol</term>
<term>Microvascular disease</term>
<term>Minimal weight gain</term>
<term>More participants</term>
<term>More patients</term>
<term>Multivariable models</term>
<term>National health</term>
<term>Oral agents</term>
<term>Oral medications</term>
<term>Original article</term>
<term>Original article diabetes</term>
<term>Patient characteristics</term>
<term>Potential predictors</term>
<term>Predictor</term>
<term>Randomized treatment</term>
<term>Sensitivity analysis</term>
<term>Several studies</term>
<term>Standard treatment</term>
<term>Substantial weight gain</term>
<term>Sulphonylurea</term>
<term>Sulphonylurea metformin</term>
<term>Sulphonylurea thiazol</term>
<term>Thiazolidinedione</term>
<term>Treatment allocation</term>
<term>Treatment combinations</term>
<term>Vascular disease</term>
<term>Vascular outcomes</term>
<term>Weight change</term>
<term>Weight changes</term>
<term>Weight gain</term>
<term>Weight gain group</term>
<term>Weight loss</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Collecte de données</term>
<term>Diabète</term>
<term>Glucose</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Aims: To determine the baseline characteristics and glucose‐lowering therapies associated with weight change among patients with type 2 diabetes.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005561 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 005561 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:305AA8190450073B3A0E52A1597718EF0CFD6E6B |texte= Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial }}
This area was generated with Dilib version V0.6.33. |